

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 8.02553982 |
| 2 | regulation of interferon-beta biosynthetic process (GO:0045357) | 7.24614116 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.47101771 |
| 4 | B cell proliferation (GO:0042100) | 6.03367226 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.92034325 |
| 6 | regulation of B cell differentiation (GO:0045577) | 5.48518113 |
| 7 | mature B cell differentiation (GO:0002335) | 5.27049515 |
| 8 | protein K11-linked deubiquitination (GO:0035871) | 5.21943516 |
| 9 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 5.01804025 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 4.96811538 |
| 11 | * regulation of B cell receptor signaling pathway (GO:0050855) | 4.84444877 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 4.83830818 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.78203229 |
| 14 | response to interleukin-15 (GO:0070672) | 4.76377944 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.69153600 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.69153600 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.68835273 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.68835273 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.68835273 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.68835273 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.68835273 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.68835273 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 4.65317837 |
| 24 | regulation of B cell proliferation (GO:0030888) | 4.51370897 |
| 25 | negative regulation of B cell proliferation (GO:0030889) | 4.50354173 |
| 26 | indole-containing compound catabolic process (GO:0042436) | 4.49945876 |
| 27 | indolalkylamine catabolic process (GO:0046218) | 4.49945876 |
| 28 | tryptophan catabolic process (GO:0006569) | 4.49945876 |
| 29 | I-kappaB phosphorylation (GO:0007252) | 4.43717090 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.40979446 |
| 31 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.36958039 |
| 32 | positive thymic T cell selection (GO:0045059) | 4.32410356 |
| 33 | cellular response to zinc ion (GO:0071294) | 4.20555284 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 4.19702280 |
| 35 | positive regulation of developmental pigmentation (GO:0048087) | 4.12845154 |
| 36 | defense response to protozoan (GO:0042832) | 4.07184213 |
| 37 | protein K48-linked deubiquitination (GO:0071108) | 4.02968339 |
| 38 | B cell homeostasis (GO:0001782) | 4.02955756 |
| 39 | indolalkylamine metabolic process (GO:0006586) | 4.01960831 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.97164946 |
| 41 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93671100 |
| 42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.88176586 |
| 43 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.86797371 |
| 44 | phospholipid translocation (GO:0045332) | 3.85606614 |
| 45 | lipid translocation (GO:0034204) | 3.85606614 |
| 46 | signal peptide processing (GO:0006465) | 3.84401375 |
| 47 | B cell activation (GO:0042113) | 3.84260778 |
| 48 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.82226207 |
| 49 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.81990394 |
| 50 | neural tube formation (GO:0001841) | 3.80947659 |
| 51 | tryptophan metabolic process (GO:0006568) | 3.79966636 |
| 52 | NIK/NF-kappaB signaling (GO:0038061) | 3.79808336 |
| 53 | positive regulation of interleukin-12 production (GO:0032735) | 3.77234492 |
| 54 | respiratory burst (GO:0045730) | 3.75614085 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.74870026 |
| 56 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.74300480 |
| 57 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.70408834 |
| 58 | positive regulation of interferon-beta production (GO:0032728) | 3.69349923 |
| 59 | positive regulation of B cell proliferation (GO:0030890) | 3.67579407 |
| 60 | establishment of protein localization to Golgi (GO:0072600) | 3.67364715 |
| 61 | regulation of establishment of cell polarity (GO:2000114) | 3.64104538 |
| 62 | protein K63-linked deubiquitination (GO:0070536) | 3.63577554 |
| 63 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.61523604 |
| 64 | kynurenine metabolic process (GO:0070189) | 3.59573329 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57457033 |
| 66 | lymphocyte proliferation (GO:0046651) | 3.57293852 |
| 67 | mononuclear cell proliferation (GO:0032943) | 3.54709765 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.53202609 |
| 69 | positive regulation of interleukin-2 production (GO:0032743) | 3.52750935 |
| 70 | response to protozoan (GO:0001562) | 3.51362680 |
| 71 | cellular response to ethanol (GO:0071361) | 3.48266770 |
| 72 | regulation of pigment cell differentiation (GO:0050932) | 3.47051246 |
| 73 | positive regulation of B cell activation (GO:0050871) | 3.41778033 |
| 74 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.41370879 |
| 75 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40370367 |
| 76 | regulation of sarcomere organization (GO:0060297) | 3.38417753 |
| 77 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.38362836 |
| 78 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.36341159 |
| 79 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.36123067 |
| 80 | regulation of B cell activation (GO:0050864) | 3.35367112 |
| 81 | mature B cell differentiation involved in immune response (GO:0002313) | 3.35012743 |
| 82 | lymph node development (GO:0048535) | 3.34175998 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.34003987 |
| 84 | response to host immune response (GO:0052572) | 3.34003987 |
| 85 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.33194039 |
| 86 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.32578602 |
| 87 | cellular response to exogenous dsRNA (GO:0071360) | 3.31545161 |
| 88 | lymphocyte homeostasis (GO:0002260) | 3.31525094 |
| 89 | tachykinin receptor signaling pathway (GO:0007217) | 3.30882270 |
| 90 | negative regulation of mast cell activation (GO:0033004) | 3.30492509 |
| 91 | immunoglobulin mediated immune response (GO:0016064) | 3.29041984 |
| 92 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.26773672 |
| 93 | positive T cell selection (GO:0043368) | 3.26011248 |
| 94 | histone H3-K9 modification (GO:0061647) | 3.24996132 |
| 95 | regulation of interleukin-12 production (GO:0032655) | 3.22990566 |
| 96 | germinal center formation (GO:0002467) | 3.22871092 |
| 97 | leukocyte aggregation (GO:0070486) | 3.22813729 |
| 98 | histone H3-K9 methylation (GO:0051567) | 3.19187875 |
| 99 | leukocyte proliferation (GO:0070661) | 3.15148524 |
| 100 | thymic T cell selection (GO:0045061) | 3.14389807 |
| 101 | neutrophil activation (GO:0042119) | 3.13718524 |
| 102 | T cell selection (GO:0045058) | 3.12838005 |
| 103 | B cell differentiation (GO:0030183) | 3.12143978 |
| 104 | response to host (GO:0075136) | 3.12139833 |
| 105 | response to host defenses (GO:0052200) | 3.12139833 |
| 106 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.12139833 |
| 107 | interferon-gamma production (GO:0032609) | 3.10970721 |
| 108 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.09922682 |
| 109 | snRNA transcription (GO:0009301) | 3.05722821 |
| 110 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 3.04867618 |
| 111 | positive regulation of interleukin-10 production (GO:0032733) | 3.03937012 |
| 112 | regulation of B cell apoptotic process (GO:0002902) | 3.03520897 |
| 113 | positive regulation of macrophage cytokine production (GO:0060907) | 3.02486017 |
| 114 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.02312815 |
| 115 | regulation of interferon-beta production (GO:0032648) | 2.98505837 |
| 116 | negative thymic T cell selection (GO:0045060) | 2.97581178 |
| 117 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.95989194 |
| 118 | positive regulation of immunoglobulin production (GO:0002639) | 2.95420463 |
| 119 | superoxide anion generation (GO:0042554) | 2.94882338 |
| 120 | T cell homeostasis (GO:0043029) | 2.93162186 |
| 121 | NAD biosynthetic process (GO:0009435) | 2.92261686 |
| 122 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.91998334 |
| 123 | interkinetic nuclear migration (GO:0022027) | 2.91553186 |
| 124 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.91543186 |
| 125 | granulocyte activation (GO:0036230) | 2.89714569 |
| 126 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.88790826 |
| 127 | detection of light stimulus involved in visual perception (GO:0050908) | 2.88790826 |
| 128 | histone H3-K4 trimethylation (GO:0080182) | 2.88428646 |
| 129 | T cell migration (GO:0072678) | 2.87723805 |
| 130 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87476349 |
| 131 | negative regulation of histone methylation (GO:0031061) | 2.85930770 |
| 132 | regulation of RIG-I signaling pathway (GO:0039535) | 2.85881826 |
| 133 | regulation of antigen processing and presentation (GO:0002577) | 2.85289562 |
| 134 | indole-containing compound metabolic process (GO:0042430) | 2.84672956 |
| 135 | regulation of hippo signaling (GO:0035330) | 2.84594732 |
| 136 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.83911571 |
| 137 | positive regulation of type 2 immune response (GO:0002830) | 2.83601129 |
| 138 | negative regulation of bone resorption (GO:0045779) | 2.82059679 |
| 139 | flavonoid metabolic process (GO:0009812) | 2.80272794 |
| 140 | thyroid hormone metabolic process (GO:0042403) | 2.80163315 |
| 141 | cellular biogenic amine catabolic process (GO:0042402) | 2.77391605 |
| 142 | amine catabolic process (GO:0009310) | 2.77391605 |
| 143 | disruption of cells of other organism (GO:0044364) | 2.76450717 |
| 144 | killing of cells of other organism (GO:0031640) | 2.76450717 |
| 145 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.76095973 |
| 146 | reflex (GO:0060004) | 2.72530968 |
| 147 | photoreceptor cell maintenance (GO:0045494) | 2.71477437 |
| 148 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.69106335 |
| 149 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69036687 |
| 150 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.69036687 |
| 151 | response to type I interferon (GO:0034340) | 2.64274320 |
| 152 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.60014597 |
| 153 | type I interferon signaling pathway (GO:0060337) | 2.57974531 |
| 154 | cellular response to type I interferon (GO:0071357) | 2.57974531 |
| 155 | protein targeting to Golgi (GO:0000042) | 2.57394599 |
| 156 | sphingoid metabolic process (GO:0046519) | 2.56274112 |
| 157 | positive regulation of granulocyte differentiation (GO:0030854) | 2.55746467 |
| 158 | regulation of memory T cell differentiation (GO:0043380) | 2.54557069 |
| 159 | negative T cell selection (GO:0043383) | 2.54471053 |
| 160 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53971978 |
| 161 | striated muscle atrophy (GO:0014891) | 2.52628830 |
| 162 | cytokine biosynthetic process (GO:0042089) | 2.48822355 |
| 163 | regulation of gene silencing by miRNA (GO:0060964) | 2.46015385 |
| 164 | regulation of gene silencing by RNA (GO:0060966) | 2.46015385 |
| 165 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.46015385 |
| 166 | fucose catabolic process (GO:0019317) | 2.45881844 |
| 167 | L-fucose metabolic process (GO:0042354) | 2.45881844 |
| 168 | L-fucose catabolic process (GO:0042355) | 2.45881844 |
| 169 | activated T cell proliferation (GO:0050798) | 2.45581094 |
| 170 | hepatocyte apoptotic process (GO:0097284) | 2.44335961 |
| 171 | benzene-containing compound metabolic process (GO:0042537) | 2.44278847 |
| 172 | negative regulation of B cell mediated immunity (GO:0002713) | 2.43887981 |
| 173 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.43887981 |
| 174 | sulfation (GO:0051923) | 2.42624228 |
| 175 | regulation of membrane lipid distribution (GO:0097035) | 2.39972248 |
| 176 | positive regulation of defense response to virus by host (GO:0002230) | 2.38803084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.79774190 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.54295796 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.18008258 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.43804388 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.42470135 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.91507070 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.76499863 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72348258 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.56763423 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41697836 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.19614417 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.07294459 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.05854895 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.98550616 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.93856368 |
| 16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.85112087 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.82663317 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.79247950 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77977119 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70267944 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.68615959 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.58574612 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.43902812 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42712110 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.41092992 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 2.39870651 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32805332 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.32128699 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.31832299 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.27273862 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.25519720 |
| 32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.24306782 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22992349 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.21246583 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.18313432 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17874812 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16811863 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14477758 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13053548 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 2.04850759 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.04815136 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01701741 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00859560 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95272852 |
| 45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.94131610 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.91525026 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.91128629 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86085579 |
| 49 | STAT3_23295773_ChIP-Seq_U87_Human | 1.84514592 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83455333 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.83114887 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79405864 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.79223421 |
| 54 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.72789693 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.72620879 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70711768 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69455241 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69311715 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68254636 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.68223945 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.64314658 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64188152 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63486452 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62851090 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60373927 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59916373 |
| 67 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.59068846 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56048261 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55784353 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55201044 |
| 71 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.54982818 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52829061 |
| 73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52507672 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50927755 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50867192 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.50423778 |
| 77 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48623456 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47357858 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45738349 |
| 80 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44569040 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.43828094 |
| 82 | EWS_26573619_Chip-Seq_HEK293_Human | 1.43658545 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.42649521 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41740890 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.40735314 |
| 86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39521034 |
| 87 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.38235414 |
| 88 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38235414 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37682855 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.37371524 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37241295 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37209417 |
| 93 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.35556538 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33588013 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.33029306 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.33029306 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.32538716 |
| 98 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31907165 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31413977 |
| 100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29237031 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27020521 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26568717 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25066825 |
| 104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25023424 |
| 105 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24000687 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22826906 |
| 107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.22365731 |
| 108 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20267752 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20263413 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.20058193 |
| 111 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19721317 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19651270 |
| 113 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18584884 |
| 114 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18566442 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18477237 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18018048 |
| 117 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17791879 |
| 118 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.17226948 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16595647 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14621579 |
| 121 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.14539369 |
| 122 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.14278537 |
| 123 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12020904 |
| 124 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11269986 |
| 125 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10339704 |
| 126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09980352 |
| 127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.09437715 |
| 128 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08793489 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08341045 |
| 130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07512446 |
| 131 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07442299 |
| 132 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07436192 |
| 133 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06721002 |
| 134 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05885135 |
| 135 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04913941 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04721378 |
| 137 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03370183 |
| 138 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02842994 |
| 139 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01512409 |
| 140 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00833616 |
| 141 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00381649 |
| 142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00342285 |
| 143 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99730481 |
| 144 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99565174 |
| 145 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.98685364 |
| 146 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96572618 |
| 147 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96096545 |
| 148 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96068995 |
| 149 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95554406 |
| 150 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.95411998 |
| 151 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94901842 |
| 152 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93692649 |
| 153 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93574795 |
| 154 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90662866 |
| 155 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82710600 |
| 156 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.82404811 |
| 157 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82151659 |
| 158 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80767658 |
| 159 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79545832 |
| 160 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78973562 |
| 161 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78696939 |
| 162 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77630269 |
| 163 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.75766257 |
| 164 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73044457 |
| 165 | GATA3_26560356_Chip-Seq_TH1_Human | 0.72672743 |
| 166 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71867053 |
| 167 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71272517 |
| 168 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70999961 |
| 169 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70035510 |
| 170 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.68926323 |
| 171 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.66266546 |
| 172 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.65186832 |
| 173 | P300_27268052_Chip-Seq_Bcells_Human | 0.64726383 |
| 174 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.64282738 |
| 175 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.64093680 |
| 176 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.64058041 |
| 177 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.63712415 |
| 178 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.62840890 |
| 179 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.61869573 |
| 180 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.60477777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.93707448 |
| 2 | MP0001800_abnormal_humoral_immune | 5.02742585 |
| 3 | MP0005387_immune_system_phenotype | 5.01964381 |
| 4 | MP0001790_abnormal_immune_system | 5.01964381 |
| 5 | MP0002452_abnormal_antigen_presenting | 3.92856718 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.81464565 |
| 7 | MP0000685_abnormal_immune_system | 3.76991781 |
| 8 | MP0003303_peritoneal_inflammation | 3.67108897 |
| 9 | MP0002723_abnormal_immune_serum | 3.31030837 |
| 10 | MP0002420_abnormal_adaptive_immunity | 3.16045580 |
| 11 | MP0001819_abnormal_immune_cell | 3.05766612 |
| 12 | MP0005671_abnormal_response_to | 2.91330817 |
| 13 | MP0002398_abnormal_bone_marrow | 2.76324178 |
| 14 | MP0000716_abnormal_immune_system | 2.62411964 |
| 15 | MP0000689_abnormal_spleen_morphology | 2.42027178 |
| 16 | MP0005025_abnormal_response_to | 2.41150941 |
| 17 | MP0002419_abnormal_innate_immunity | 2.34169650 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.26143648 |
| 19 | MP0001873_stomach_inflammation | 2.23186571 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.19898671 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.13578946 |
| 22 | MP0009785_altered_susceptibility_to | 2.12654268 |
| 23 | MP0002429_abnormal_blood_cell | 2.11022851 |
| 24 | MP0001501_abnormal_sleep_pattern | 2.08353908 |
| 25 | MP0004043_abnormal_pH_regulation | 1.99432368 |
| 26 | MP0002722_abnormal_immune_system | 1.97606593 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.93619012 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 1.93267051 |
| 29 | MP0003436_decreased_susceptibility_to | 1.92916875 |
| 30 | MP0003195_calcinosis | 1.89682826 |
| 31 | MP0003646_muscle_fatigue | 1.87862425 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.86240841 |
| 33 | MP0008877_abnormal_DNA_methylation | 1.83743997 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.75829825 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.74366136 |
| 36 | MP0004510_myositis | 1.71119655 |
| 37 | MP0002405_respiratory_system_inflammati | 1.70437313 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.64392923 |
| 39 | MP0009046_muscle_twitch | 1.62671283 |
| 40 | MP0005310_abnormal_salivary_gland | 1.61648376 |
| 41 | MP0004381_abnormal_hair_follicle | 1.61553217 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.60265993 |
| 43 | MP0008057_abnormal_DNA_replication | 1.60180934 |
| 44 | MP0003252_abnormal_bile_duct | 1.53699012 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.49701940 |
| 46 | MP0004947_skin_inflammation | 1.49403791 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.48029101 |
| 48 | MP0001853_heart_inflammation | 1.41383093 |
| 49 | MP0003091_abnormal_cell_migration | 1.38046196 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.32197629 |
| 51 | MP0002006_tumorigenesis | 1.30393478 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.30098285 |
| 53 | MP0000427_abnormal_hair_cycle | 1.29706243 |
| 54 | MP0006082_CNS_inflammation | 1.29422989 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.28764294 |
| 56 | MP0005670_abnormal_white_adipose | 1.28544989 |
| 57 | MP0000703_abnormal_thymus_morphology | 1.28507099 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.27005236 |
| 59 | MP0009745_abnormal_behavioral_response | 1.24732266 |
| 60 | MP0008872_abnormal_physiological_respon | 1.23011210 |
| 61 | MP0005451_abnormal_body_composition | 1.21249316 |
| 62 | MP0002736_abnormal_nociception_after | 1.20355442 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.19803327 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.19379504 |
| 65 | MP0008260_abnormal_autophagy | 1.17874713 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.17836432 |
| 67 | MP0002168_other_aberrant_phenotype | 1.16833983 |
| 68 | MP0002933_joint_inflammation | 1.14859587 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.14225205 |
| 70 | MP0009764_decreased_sensitivity_to | 1.13239710 |
| 71 | MP0002254_reproductive_system_inflammat | 1.12633603 |
| 72 | MP0003787_abnormal_imprinting | 1.11054500 |
| 73 | MP0000767_abnormal_smooth_muscle | 1.10052091 |
| 74 | MP0006054_spinal_hemorrhage | 1.09873996 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 1.07769580 |
| 76 | MP0008469_abnormal_protein_level | 1.06518760 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.03997151 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.01930774 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.99635742 |
| 80 | MP0000015_abnormal_ear_pigmentation | 0.99092776 |
| 81 | MP0000383_abnormal_hair_follicle | 0.99089611 |
| 82 | MP0002009_preneoplasia | 0.96766708 |
| 83 | MP0004142_abnormal_muscle_tone | 0.96757371 |
| 84 | MP0003866_abnormal_defecation | 0.92759154 |
| 85 | MP0005253_abnormal_eye_physiology | 0.91487148 |
| 86 | MP0002735_abnormal_chemical_nociception | 0.90219953 |
| 87 | MP0003724_increased_susceptibility_to | 0.89237173 |
| 88 | MP0003077_abnormal_cell_cycle | 0.87983210 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.85998330 |
| 90 | MP0005166_decreased_susceptibility_to | 0.85928183 |
| 91 | MP0001486_abnormal_startle_reflex | 0.85440949 |
| 92 | MP0002928_abnormal_bile_duct | 0.84680835 |
| 93 | MP0010094_abnormal_chromosome_stability | 0.83662452 |
| 94 | MP0002067_abnormal_sensory_capabilities | 0.83047640 |
| 95 | MP0000490_abnormal_crypts_of | 0.82206380 |
| 96 | MP0002064_seizures | 0.81846220 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.81282923 |
| 98 | MP0005647_abnormal_sex_gland | 0.80732668 |
| 99 | MP0005266_abnormal_metabolism | 0.79058963 |
| 100 | MP0001663_abnormal_digestive_system | 0.78487956 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.76308325 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.75868478 |
| 103 | MP0001533_abnormal_skeleton_physiology | 0.75390742 |
| 104 | MP0003693_abnormal_embryo_hatching | 0.75034520 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.74721716 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.73214749 |
| 107 | MP0001879_abnormal_lymphatic_vessel | 0.72980778 |
| 108 | MP0003045_fibrosis | 0.72503653 |
| 109 | MP0003828_pulmonary_edema | 0.72411888 |
| 110 | MP0004924_abnormal_behavior | 0.72354540 |
| 111 | MP0005386_behavior/neurological_phenoty | 0.72354540 |
| 112 | MP0005085_abnormal_gallbladder_physiolo | 0.71475916 |
| 113 | MP0003111_abnormal_nucleus_morphology | 0.71370548 |
| 114 | MP0008874_decreased_physiological_sensi | 0.70909864 |
| 115 | MP0002876_abnormal_thyroid_physiology | 0.69847265 |
| 116 | MP0005257_abnormal_intraocular_pressure | 0.69242984 |
| 117 | MP0005621_abnormal_cell_physiology | 0.69161759 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.66525009 |
| 119 | MP0001764_abnormal_homeostasis | 0.66107005 |
| 120 | MP0003448_altered_tumor_morphology | 0.66064753 |
| 121 | MP0005395_other_phenotype | 0.65380693 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.64566795 |
| 123 | MP0001970_abnormal_pain_threshold | 0.62244406 |
| 124 | MP0002733_abnormal_thermal_nociception | 0.62199041 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.61853960 |
| 126 | MP0009115_abnormal_fat_cell | 0.61717484 |
| 127 | MP0002229_neurodegeneration | 0.61649196 |
| 128 | MP0000249_abnormal_blood_vessel | 0.60188368 |
| 129 | MP0003633_abnormal_nervous_system | 0.59910347 |
| 130 | MP0005167_abnormal_blood-brain_barrier | 0.59139732 |
| 131 | MP0002139_abnormal_hepatobiliary_system | 0.59015847 |
| 132 | MP0008058_abnormal_DNA_repair | 0.57460391 |
| 133 | MP0002693_abnormal_pancreas_physiology | 0.52560313 |
| 134 | MP0000371_diluted_coat_color | 0.51866295 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.49728716 |
| 136 | MP0001986_abnormal_taste_sensitivity | 0.49298466 |
| 137 | MP0009278_abnormal_bone_marrow | 0.48314808 |
| 138 | MP0000858_altered_metastatic_potential | 0.47620307 |
| 139 | MP0000350_abnormal_cell_proliferation | 0.46027874 |
| 140 | MP0002277_abnormal_respiratory_mucosa | 0.45337656 |
| 141 | MP0002909_abnormal_adrenal_gland | 0.44882706 |
| 142 | MP0000313_abnormal_cell_death | 0.44188771 |
| 143 | MP0002998_abnormal_bone_remodeling | 0.43596025 |
| 144 | MP0009763_increased_sensitivity_to | 0.42294026 |
| 145 | MP0003566_abnormal_cell_adhesion | 0.41706426 |
| 146 | MP0003191_abnormal_cellular_cholesterol | 0.41325631 |
| 147 | MP0005384_cellular_phenotype | 0.40129571 |
| 148 | MP0001186_pigmentation_phenotype | 0.37756198 |
| 149 | MP0005390_skeleton_phenotype | 0.37208538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal stroma tumor (HP:0100723) | 8.25059860 |
| 2 | Agammaglobulinemia (HP:0004432) | 8.17525805 |
| 3 | Recurrent sinusitis (HP:0011108) | 6.46115770 |
| 4 | Colitis (HP:0002583) | 5.90955788 |
| 5 | Cellulitis (HP:0100658) | 5.68656978 |
| 6 | Recurrent bronchitis (HP:0002837) | 5.52936088 |
| 7 | IgM deficiency (HP:0002850) | 5.44115909 |
| 8 | Emphysema (HP:0002097) | 5.08865549 |
| 9 | Recurrent abscess formation (HP:0002722) | 5.01993023 |
| 10 | Inflammation of the large intestine (HP:0002037) | 4.98266027 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.97610249 |
| 12 | Recurrent viral infections (HP:0004429) | 4.93500928 |
| 13 | Lymphopenia (HP:0001888) | 4.86402960 |
| 14 | IgA deficiency (HP:0002720) | 4.81033931 |
| 15 | Gastrointestinal inflammation (HP:0004386) | 4.66708762 |
| 16 | Vasculitis (HP:0002633) | 4.61127172 |
| 17 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.56204043 |
| 18 | Meningitis (HP:0001287) | 4.53218700 |
| 19 | Genetic anticipation (HP:0003743) | 4.51705235 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 4.51286470 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.16875753 |
| 22 | Eczematoid dermatitis (HP:0000976) | 4.09138837 |
| 23 | Hyperventilation (HP:0002883) | 4.08785376 |
| 24 | Recurrent pneumonia (HP:0006532) | 4.06879069 |
| 25 | Papilloma (HP:0012740) | 4.06096334 |
| 26 | Verrucae (HP:0200043) | 4.06096334 |
| 27 | Chronic sinusitis (HP:0011109) | 4.04565550 |
| 28 | Panhypogammaglobulinemia (HP:0003139) | 3.93608308 |
| 29 | Chronic diarrhea (HP:0002028) | 3.91799690 |
| 30 | Restrictive lung disease (HP:0002091) | 3.91509136 |
| 31 | Gaze-evoked nystagmus (HP:0000640) | 3.90540017 |
| 32 | Chronic otitis media (HP:0000389) | 3.82205150 |
| 33 | Recurrent lower respiratory tract infections (HP:0002783) | 3.70093497 |
| 34 | Recurrent fungal infections (HP:0002841) | 3.62767649 |
| 35 | Progressive cerebellar ataxia (HP:0002073) | 3.56776781 |
| 36 | Osteomyelitis (HP:0002754) | 3.54416695 |
| 37 | Recurrent skin infections (HP:0001581) | 3.50019630 |
| 38 | Pancreatic cysts (HP:0001737) | 3.49331541 |
| 39 | Small epiphyses (HP:0010585) | 3.47502029 |
| 40 | Leukopenia (HP:0001882) | 3.34448128 |
| 41 | Congenital stationary night blindness (HP:0007642) | 3.32739554 |
| 42 | Recurrent otitis media (HP:0000403) | 3.29086552 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 3.24033217 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.24033217 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.19890821 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13775455 |
| 47 | Obstructive lung disease (HP:0006536) | 3.13775455 |
| 48 | Clumsiness (HP:0002312) | 3.09199794 |
| 49 | Bronchitis (HP:0012387) | 3.05383522 |
| 50 | Attenuation of retinal blood vessels (HP:0007843) | 3.03537350 |
| 51 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.01192259 |
| 52 | Protruding tongue (HP:0010808) | 2.99746728 |
| 53 | Congenital sensorineural hearing impairment (HP:0008527) | 2.92471420 |
| 54 | B lymphocytopenia (HP:0010976) | 2.90699986 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.90699986 |
| 56 | Prostate neoplasm (HP:0100787) | 2.81303358 |
| 57 | True hermaphroditism (HP:0010459) | 2.78997129 |
| 58 | Sepsis (HP:0100806) | 2.78442837 |
| 59 | Pancreatic fibrosis (HP:0100732) | 2.78279696 |
| 60 | Lymphoma (HP:0002665) | 2.78099590 |
| 61 | Stomach cancer (HP:0012126) | 2.77274557 |
| 62 | Abnormality of the prostate (HP:0008775) | 2.77236716 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.72006718 |
| 64 | Chronic hepatic failure (HP:0100626) | 2.71161479 |
| 65 | Absent speech (HP:0001344) | 2.68139423 |
| 66 | Abnormality of the fingertips (HP:0001211) | 2.66481598 |
| 67 | Febrile seizures (HP:0002373) | 2.57212133 |
| 68 | Pustule (HP:0200039) | 2.56301232 |
| 69 | Nasal polyposis (HP:0100582) | 2.55978316 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 2.55952253 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55363442 |
| 72 | Viral hepatitis (HP:0006562) | 2.51921980 |
| 73 | Fair hair (HP:0002286) | 2.47709132 |
| 74 | IgG deficiency (HP:0004315) | 2.44603047 |
| 75 | Anomalous pulmonary venous return (HP:0010772) | 2.42376813 |
| 76 | Abnormality of the intervertebral disk (HP:0005108) | 2.41813875 |
| 77 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.41545737 |
| 78 | Mitral stenosis (HP:0001718) | 2.39198776 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 2.36757834 |
| 80 | Stomatitis (HP:0010280) | 2.36368362 |
| 81 | Abnormality of T cell physiology (HP:0011840) | 2.32999731 |
| 82 | Gingivitis (HP:0000230) | 2.30992733 |
| 83 | Abnormality of T cells (HP:0002843) | 2.28063404 |
| 84 | Thyroiditis (HP:0100646) | 2.27233419 |
| 85 | Arthralgia (HP:0002829) | 2.27098831 |
| 86 | Encephalitis (HP:0002383) | 2.24606815 |
| 87 | Abolished electroretinogram (ERG) (HP:0000550) | 2.21564625 |
| 88 | Skin ulcer (HP:0200042) | 2.20525486 |
| 89 | Cystic liver disease (HP:0006706) | 2.20093644 |
| 90 | Decreased circulating renin level (HP:0003351) | 2.19312162 |
| 91 | Hematochezia (HP:0002573) | 2.19098607 |
| 92 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.19021433 |
| 93 | Dysmetric saccades (HP:0000641) | 2.19014888 |
| 94 | Autoimmune thrombocytopenia (HP:0001973) | 2.18100590 |
| 95 | Abnormality of macrophages (HP:0004311) | 2.16596654 |
| 96 | Flattened epiphyses (HP:0003071) | 2.16250547 |
| 97 | Abnormality of midbrain morphology (HP:0002418) | 2.13453272 |
| 98 | Molar tooth sign on MRI (HP:0002419) | 2.13453272 |
| 99 | Facial diplegia (HP:0001349) | 2.12717327 |
| 100 | Widely spaced teeth (HP:0000687) | 2.10023477 |
| 101 | Thrombocytosis (HP:0001894) | 2.09752595 |
| 102 | Abnormality of the renal medulla (HP:0100957) | 2.08126055 |
| 103 | Nephronophthisis (HP:0000090) | 2.06003146 |
| 104 | Periodontitis (HP:0000704) | 2.05484224 |
| 105 | Abnormality of the pulmonary veins (HP:0011718) | 2.05427305 |
| 106 | Generalized hypopigmentation of hair (HP:0011358) | 2.04541466 |
| 107 | Dialeptic seizures (HP:0011146) | 2.04416683 |
| 108 | Hypoplastic ischia (HP:0003175) | 2.04171701 |
| 109 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02406487 |
| 110 | Abnormality of the nasal mucosa (HP:0000433) | 2.02357071 |
| 111 | Central scotoma (HP:0000603) | 2.01985035 |
| 112 | Abnormality of male internal genitalia (HP:0000022) | 2.01769199 |
| 113 | T lymphocytopenia (HP:0005403) | 2.01033522 |
| 114 | Myositis (HP:0100614) | 1.99063479 |
| 115 | Neutropenia (HP:0001875) | 1.95189681 |
| 116 | Abnormality of T cell number (HP:0011839) | 1.93874659 |
| 117 | Spontaneous hematomas (HP:0007420) | 1.92191664 |
| 118 | Increased corneal curvature (HP:0100692) | 1.92070479 |
| 119 | Keratoconus (HP:0000563) | 1.92070479 |
| 120 | Focal seizures (HP:0007359) | 1.91928429 |
| 121 | Irregular vertebral endplates (HP:0003301) | 1.90678905 |
| 122 | Retrobulbar optic neuritis (HP:0100654) | 1.88128300 |
| 123 | Optic neuritis (HP:0100653) | 1.88128300 |
| 124 | Progressive inability to walk (HP:0002505) | 1.88036745 |
| 125 | Fatigue (HP:0012378) | 1.87938070 |
| 126 | Inability to walk (HP:0002540) | 1.87514597 |
| 127 | Myocardial infarction (HP:0001658) | 1.87200861 |
| 128 | Hemoptysis (HP:0002105) | 1.87166675 |
| 129 | Xerostomia (HP:0000217) | 1.85866885 |
| 130 | Acrocyanosis (HP:0001063) | 1.85585970 |
| 131 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.85322161 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.85168572 |
| 133 | Keratoconjunctivitis (HP:0001096) | 1.84197091 |
| 134 | Skin rash (HP:0000988) | 1.82844362 |
| 135 | Increased IgE level (HP:0003212) | 1.81137084 |
| 136 | Abnormality of the ischium (HP:0003174) | 1.80395785 |
| 137 | Urticaria (HP:0001025) | 1.80057279 |
| 138 | Medial flaring of the eyebrow (HP:0010747) | 1.78344185 |
| 139 | Poikiloderma (HP:0001029) | 1.78340957 |
| 140 | Bile duct proliferation (HP:0001408) | 1.78243447 |
| 141 | Abnormal biliary tract physiology (HP:0012439) | 1.78243447 |
| 142 | Vertebral arch anomaly (HP:0008438) | 1.78169127 |
| 143 | Absence seizures (HP:0002121) | 1.78139383 |
| 144 | Abnormality of binocular vision (HP:0011514) | 1.77692101 |
| 145 | Diplopia (HP:0000651) | 1.77692101 |
| 146 | Albinism (HP:0001022) | 1.77260030 |
| 147 | Chest pain (HP:0100749) | 1.76188208 |
| 148 | Abnormality of DNA repair (HP:0003254) | 1.74234243 |
| 149 | Arterial thrombosis (HP:0004420) | 1.73979527 |
| 150 | Bronchiectasis (HP:0002110) | 1.72639839 |
| 151 | Absent epiphyses (HP:0010577) | 1.71594581 |
| 152 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.71594581 |
| 153 | Clubbing of toes (HP:0100760) | 1.65049646 |
| 154 | Abnormality of the vertebral endplates (HP:0005106) | 1.56880942 |
| 155 | Hepatitis (HP:0012115) | 1.55076002 |
| 156 | Basal ganglia calcification (HP:0002135) | 1.50828741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 9.57170118 |
| 2 | MAP4K1 | 6.84608084 |
| 3 | CDK12 | 3.63746571 |
| 4 | BLK | 3.60470476 |
| 5 | CSF1R | 2.95182491 |
| 6 | IRAK3 | 2.91196802 |
| 7 | ERN1 | 2.84651856 |
| 8 | JAK1 | 2.81460807 |
| 9 | ACVR1B | 2.76442625 |
| 10 | MAP3K14 | 2.65170433 |
| 11 | MAP3K13 | 2.48560770 |
| 12 | RIPK4 | 2.47752260 |
| 13 | TYK2 | 2.36630957 |
| 14 | SYK | 2.34180864 |
| 15 | BTK | 2.33673536 |
| 16 | BRD4 | 2.26898961 |
| 17 | GRK6 | 2.20212541 |
| 18 | STK10 | 2.11311037 |
| 19 | SIK2 | 1.98732248 |
| 20 | BMPR1B | 1.93128830 |
| 21 | WNK3 | 1.85383699 |
| 22 | IKBKB | 1.76377318 |
| 23 | LRRK2 | 1.74385153 |
| 24 | JAK3 | 1.68734323 |
| 25 | EIF2AK3 | 1.66319837 |
| 26 | ADRBK2 | 1.63764725 |
| 27 | IRAK4 | 1.55338763 |
| 28 | MAPK13 | 1.48493689 |
| 29 | LYN | 1.48246357 |
| 30 | SIK3 | 1.46933872 |
| 31 | MKNK2 | 1.45849234 |
| 32 | KIT | 1.42942230 |
| 33 | GRK1 | 1.41741473 |
| 34 | HCK | 1.41728150 |
| 35 | TBK1 | 1.38808543 |
| 36 | PIK3CG | 1.38306133 |
| 37 | FES | 1.37488919 |
| 38 | NTRK3 | 1.35715360 |
| 39 | IRAK1 | 1.34935641 |
| 40 | CSK | 1.30371659 |
| 41 | OXSR1 | 1.27721475 |
| 42 | TEC | 1.24515281 |
| 43 | MARK3 | 1.22541303 |
| 44 | MST4 | 1.18426944 |
| 45 | ALK | 1.12817212 |
| 46 | PIM1 | 1.10203223 |
| 47 | STK38L | 1.07743024 |
| 48 | MAP3K10 | 1.07088659 |
| 49 | PTK2B | 0.99679999 |
| 50 | INSRR | 0.98888927 |
| 51 | PRKCQ | 0.95924891 |
| 52 | MAP4K2 | 0.95528204 |
| 53 | ZAK | 0.93814868 |
| 54 | CHUK | 0.92955949 |
| 55 | IKBKE | 0.91970311 |
| 56 | MKNK1 | 0.90738900 |
| 57 | MAP3K9 | 0.90519924 |
| 58 | ADRBK1 | 0.88295273 |
| 59 | CDK9 | 0.87046633 |
| 60 | ITK | 0.86399248 |
| 61 | LCK | 0.86043273 |
| 62 | MATK | 0.84915794 |
| 63 | BMPR2 | 0.80595124 |
| 64 | TNK2 | 0.80529177 |
| 65 | SGK2 | 0.78725891 |
| 66 | FGR | 0.78232770 |
| 67 | TRPM7 | 0.77484315 |
| 68 | NEK2 | 0.77177063 |
| 69 | ZAP70 | 0.76051785 |
| 70 | CASK | 0.74585286 |
| 71 | STK3 | 0.71326716 |
| 72 | MAPK11 | 0.70342776 |
| 73 | PINK1 | 0.70327988 |
| 74 | RPS6KA4 | 0.69875574 |
| 75 | MAPK7 | 0.68365483 |
| 76 | CDK19 | 0.67847883 |
| 77 | FER | 0.66265866 |
| 78 | STK4 | 0.65312892 |
| 79 | STK24 | 0.64175788 |
| 80 | PRKAA2 | 0.63682850 |
| 81 | TGFBR2 | 0.63070198 |
| 82 | FGFR3 | 0.61295676 |
| 83 | PRKCH | 0.60673928 |
| 84 | CLK1 | 0.59444073 |
| 85 | CDC42BPA | 0.58078238 |
| 86 | TGFBR1 | 0.58048468 |
| 87 | PAK3 | 0.57432908 |
| 88 | ABL1 | 0.56921948 |
| 89 | TAOK3 | 0.55184934 |
| 90 | PRKD2 | 0.55090429 |
| 91 | PDK1 | 0.54761589 |
| 92 | CDK4 | 0.53955837 |
| 93 | EEF2K | 0.52157463 |
| 94 | YES1 | 0.50964399 |
| 95 | AKT3 | 0.50782724 |
| 96 | HIPK2 | 0.50744038 |
| 97 | PKN1 | 0.49698398 |
| 98 | FGFR4 | 0.48250428 |
| 99 | NLK | 0.47358375 |
| 100 | MELK | 0.47353134 |
| 101 | PRKCE | 0.45112024 |
| 102 | MAP3K4 | 0.44502862 |
| 103 | TXK | 0.41911922 |
| 104 | INSR | 0.41473762 |
| 105 | STK39 | 0.39684645 |
| 106 | SIK1 | 0.38622825 |
| 107 | MAPKAPK3 | 0.37685951 |
| 108 | LATS1 | 0.37505732 |
| 109 | EPHA3 | 0.37291862 |
| 110 | JAK2 | 0.36981108 |
| 111 | BRSK2 | 0.35656949 |
| 112 | GRK5 | 0.35619673 |
| 113 | CAMK1G | 0.35284000 |
| 114 | EGFR | 0.34727593 |
| 115 | FYN | 0.34685041 |
| 116 | PIK3CA | 0.33933068 |
| 117 | CAMK1D | 0.33748764 |
| 118 | EIF2AK2 | 0.32274829 |
| 119 | EPHB1 | 0.31789777 |
| 120 | PRKAA1 | 0.31699867 |
| 121 | MAPK12 | 0.31553763 |
| 122 | PRKCZ | 0.30942028 |
| 123 | STK11 | 0.30605277 |
| 124 | PRKCD | 0.29098718 |
| 125 | PRKCB | 0.27845437 |
| 126 | SRPK1 | 0.25800601 |
| 127 | DYRK1A | 0.25405901 |
| 128 | SGK3 | 0.25386297 |
| 129 | ATR | 0.25091235 |
| 130 | PRKD1 | 0.24622793 |
| 131 | WNK1 | 0.21667659 |
| 132 | MAP3K7 | 0.21535138 |
| 133 | NUAK1 | 0.21195177 |
| 134 | TAOK2 | 0.20494608 |
| 135 | CHEK1 | 0.18463346 |
| 136 | MAPK3 | 0.18212366 |
| 137 | CDK6 | 0.17491697 |
| 138 | CSNK1A1 | 0.16424879 |
| 139 | MAP3K8 | 0.15807047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.51110650 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.97029021 |
| 3 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.56857925 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.41713448 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.09645460 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31365519 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26127228 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.16148556 |
| 9 | ABC transporters_Homo sapiens_hsa02010 | 1.97024345 |
| 10 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.95886054 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.89859578 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89627170 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84362877 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.79820933 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.78152484 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.67061549 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64331956 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63155549 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61682188 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.59117678 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54458287 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.53680207 |
| 23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.49851572 |
| 24 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.48336063 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.48223984 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.45858488 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45856565 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45311635 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.37714256 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35508086 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32671071 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31484762 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.27613892 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.26621907 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.23197555 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.22180402 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21083043 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20798765 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19430401 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17218920 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15455326 |
| 42 | Allograft rejection_Homo sapiens_hsa05330 | 1.13696036 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.10805071 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08216960 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07764533 |
| 46 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05103847 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03019883 |
| 48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.02728466 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 1.00459336 |
| 50 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99808892 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98771595 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97525990 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92013201 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.91136017 |
| 55 | Taste transduction_Homo sapiens_hsa04742 | 0.89199829 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87882618 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.87468919 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87413711 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87386501 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87031098 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85680090 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84869592 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.84844903 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82493526 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80773037 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80555546 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79771366 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78967438 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.77272599 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76828377 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.75120025 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74829212 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74264599 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72705197 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.70755726 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70612868 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70324598 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69755313 |
| 79 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69542588 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68285612 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67602167 |
| 82 | Base excision repair_Homo sapiens_hsa03410 | 0.66287795 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.66260329 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66038977 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65439548 |
| 86 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65034604 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64678861 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64634430 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64108606 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62863303 |
| 91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.62569887 |
| 92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60662938 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60377726 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59777496 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58200186 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57736300 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57500741 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57246520 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56700114 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56266239 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.55372736 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54936324 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54703899 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54055916 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53945999 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53489349 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53218564 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52165247 |
| 109 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51864514 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.51558916 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51455985 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51412602 |
| 113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50966321 |
| 114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50936748 |
| 115 | Ribosome_Homo sapiens_hsa03010 | 0.49810753 |
| 116 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49464403 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49152854 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48693446 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.46164260 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45333205 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45186653 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44631709 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43156661 |
| 124 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42204006 |
| 125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41873106 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40476174 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39677600 |
| 128 | GABAergic synapse_Homo sapiens_hsa04727 | 0.39502448 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38236407 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37773434 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.36374944 |
| 132 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36248062 |
| 133 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.34941771 |
| 134 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34836554 |
| 135 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33707041 |
| 136 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32856382 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.31447569 |
| 138 | Homologous recombination_Homo sapiens_hsa03440 | 0.31226092 |
| 139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30596011 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30393679 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29547019 |
| 142 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27618503 |
| 143 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.25226252 |
| 144 | Spliceosome_Homo sapiens_hsa03040 | 0.24611023 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.24551891 |
| 146 | Colorectal cancer_Homo sapiens_hsa05210 | 0.23577685 |
| 147 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23394456 |
| 148 | Glioma_Homo sapiens_hsa05214 | 0.23279801 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.23179757 |
| 150 | Mismatch repair_Homo sapiens_hsa03430 | 0.22567089 |
| 151 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.21919909 |
| 152 | RNA degradation_Homo sapiens_hsa03018 | 0.21364618 |
| 153 | Lysosome_Homo sapiens_hsa04142 | 0.21291287 |

